Stock GDRX GOODRX HOLDINGS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus GoodRx Holdings, Inc.

Equities

GDRX

US38246G1085

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-24 pm EDT 		5-day change 1st Jan Change
6.96 USD -0.14% Intraday chart for GoodRx Holdings, Inc. +7.08% +3.88%
Apr. 11 North American Morning Briefing : Stock Futures -2- DJ
Apr. 10 KeyBanc Upgrades GoodRx to Overweight From Sector Weight on Increased Conviction Around Monthly Active Customers, Sets $9 Price Target MT

Evolution of the average Target Price on GoodRx Holdings, Inc.

Price target over the last 5 years

History of analyst recommendation changes

edead5c.pt4UEpBMkRHH70JwMFjKFQP5-in691PuatsVjDIfgTg.7q4sc_MdomOqgnQIRR-IcUSMo2XXrz2_HrxEtWRn90LKiiRf3377X6S1MQ~2d8de721dbe64a09d180b67f2a21ac49

Analyst Recommendations on GoodRx Holdings, Inc.

KeyBanc Upgrades GoodRx to Overweight From Sector Weight on Increased Conviction Around Monthly Active Customers, Sets $9 Price Target MT
GoodRx Shares Jump Following Wells Fargo Upgrade, Price Target Boost MT
Wells Fargo Upgrades GoodRx Holdings to Overweight From Equalweight, Adjusts Price Target to $10 From $7.50 MT
Deutsche Bank Adjusts GoodRx Price Target to $9 From $7, Maintains Hold Rating MT
Goldman Sachs Raises GoodRx Holdings' Price Target to $7.50 From $6.50, Maintains Neutral Rating MT
UBS Adjusts GoodRx Holdings Price Target to $8 From $5, Maintains Neutral Rating MT
TD Cowen Adjusts Price Target on GoodRx Holdings to $14 From $12, Maintains Outperform Rating MT
Truist Adjusts Price Target on GoodRx Holdings to $8 From $7.50, Maintains Hold Rating MT
JPMorgan Adjusts GoodRx Holdings' Price Target to $7 From $6, Maintains Neutral Rating MT
RBC Raises Price Target on GoodRx Holdings to $8 From $7, Keeps Sector Perform Rating MT
Leerink Partners Initiates GoodRx Holdings at Outperform Rating With $8 Price Target MT
Goldman Sachs Raises Price Target on GoodRx to $6.50 From $6, Maintains Neutral Rating MT
RBC Raises Price Target on GoodRx Holdings to $7 From $5, Notes 'Positive Momentum,' Keeps Sector Perform Rating MT
BofA Securities Downgrades GoodRx Holdings to Underperform From Buy, Adjusts Price Target to $4.50 From $8 MT
JPMorgan Trims Price Target on GoodRx Holdings to $6 From $7, Maintains Neutral Rating MT
Goldman Sachs Trims Price Target on GoodRx Holdings to $6 From $7, Maintains Neutral Rating MT
Truist Securities Adjusts Price Target on GoodRx Holdings to $5.50 From $8, Maintains Hold Rating MT
UBS Adjusts GoodRx Price Target to $5 From $8, Maintains Neutral Rating MT
Deutsche Bank Trims GoodRx Price Target to $7 From $8, Maintains Hold Rating MT
Morgan Stanley Adjusts Price Target on GoodRx to $5.50 From $8, Maintains Equalweight Rating MT
RBC Cuts Price Target on GoodRx Holdings to $5 From $8, Keeps Sector Perform Rating MT
UBS Adjusts GoodRx Price Target to $8 From $5.50, Maintains Neutral Rating MT
JPMorgan Raises GoodRx Price Target to $6 From $5, Maintains Neutral Rating MT
Citigroup Raises GoodRx Holdings' Price Target to $11 From $7, Keeps Buy Rating MT
Evercore ISI Group Adjusts Price Target on GoodRx Holdings to $10 From $7, Keeps In Line Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
6.96 USD
Average target price
8.679 USD
Spread / Average Target
+24.70%
High Price Target
14 USD
Spread / Highest target
+101.15%
Low Price Target
5 USD
Spread / Lowest Target
-28.16%

Consensus detail

Consensus revision (last 18 months)

Analysts covering GoodRx Holdings, Inc.

KeyBanc Capital Markets
Wells Fargo Securities
Deutsche Bank Securities
Goldman Sachs
UBS
TD Cowen
Truist Securities
JPMorgan Chase
RBC Capital Markets
Leerink Partners
BofA Securities
Morgan Stanley
Citigroup
Evercore ISI
Credit Suisse
DA Davidson
Barclays
SVB Securities LLC
Guggenheim
Baird
Cowen
Raymond James
SVB Leerink
Stephens Inc.
Jefferies & Co.

Ratings for GoodRx Holdings, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. GDRX Stock
  4. Consensus GoodRx Holdings, Inc.